Alumis (ALMS) Capital Expenditures (2023 - 2025)
Alumis' (ALMS) quarterly Capital Expenditures came in at $4.9 million in Q4 2025, up 1233.88% year-on-year from $366000.0 in Q4 2024, and up 692.53% on a QoQ basis from $616000.0 in Q2 2025.
Alumis (ALMS) Capital Expenditures (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Capital Expenditures data on file, last reported at $4.9 million in Q4 2025.
- On a quarterly basis, Capital Expenditures rose 1233.88% year-over-year to $4.9 million in Q4 2025; TTM through Dec 2025 was $5.5 million, a 219.57% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 219.57% from the prior year.
- Capital Expenditures for Q4 2025 stood at $4.9 million, up from $616000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for ALMS reached as high as $4.9 million in Q4 2025 and fell as low as $37000.0 in Q1 2025.
- Historically, Capital Expenditures has averaged $1.2 million across 3 years, with a median of $616000.0 in 2025.
- On a YoY basis, Capital Expenditures climbed as much as 1233.88% in 2025 and fell as far as 76.13% in 2025.
- Year by year, Capital Expenditures stood at $1.2 million in 2023, then tumbled by 69.75% to $366000.0 in 2024, then jumped by 1233.88% to $4.9 million in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $4.9 million in Q4 2025, $616000.0 in Q2 2025, and $37000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | 4.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.88 Mn |
| Dec 31, 2025 | 4.88 Mn |
| Jun 30, 2025 | 616,000.00 |
| Jun 30, 2025 | 616,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 779,000.00 |
| Sep 30, 2024 | 779,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 155,000.00 |
| Mar 31, 2024 | 155,000.00 |
| Dec 31, 2023 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Sep 30, 2023 | 2.17 Mn |